NEW YORK (GenomeWeb) – NanoString Technologies said today that it has entered new commercial partnerships with five contract research organizations aimed at expanding access to its Digital Spatial Profiling (DSP) technology.

The agreements — with Covance, Cancer Genetics, Core Diagnostics, Propath UK, and another undisclosed company — will allow the CROS to market DSP services to their customers through a technology access program in advance of NanoString's expected commercial launch of the DSP instrument platform in 2019.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

At his FDA Law Blog, Jeffrey Gibbs discusses FDA's technical assistance for the draft Diagnostic Accuracy and Innovation Act.

The New York Times reports that genetic testing has uncovered unfaithful penguins at a Utah aquarium.

Cancer researcher loses funding under new Wellcome Trust anti-bullying policies, the Guardian reports.

In Science this week: International Wheat Genome Sequencing Consortium publishes the bread wheat cultivar Chinese Spring reference genome, and more.